0.88
-0.07%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About OrganiGram Holdings
Its shares trade under the ticker OGI. It has been listed since 27 August 2014. In the fiscal year to 30 September 2025, it reported revenue of $186.8m and a net loss of $17.8m. At that date it held total assets of $405.3m and shareholders' equity of $251.7m.
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 27 Aug 2014
- Employees
- 2
- Website
- organigram.ca ↗
- Head office
- 1400-145 KING ST. WEST, TORONTO, M5H 1J8
- Incorporated in
- Z4
- Classification
- Pharmaceutical Preparations
- Filer status
- <br>Emerging growth company
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Strong brand reputation: OrganiGram Holdings Inc has established itself as a reputable and trusted player in the cannabis industry.
- High-quality product portfolio: The company offers a diverse range of premium cannabis products known for their consistency and efficacy.
- Efficient production capabilities: OrganiGram has invested in advanced cultivation methods and technology, leading to high yields and cost efficiencies.
Weaknesses
- Limited distribution network: OrganiGram's distribution network is relatively smaller compared to some of its competitors, impacting its market reach.
- Dependence on the Canadian market: The company primarily operates in Canada, making it vulnerable to changes in the Canadian cannabis industry and regulations.
- Financial constraints: OrganiGram has faced financial challenges in the past, which may hinder its ability to invest in expansion and innovation.
Opportunities
- Growing global cannabis market: The legalization of cannabis in various countries presents an opportunity for OrganiGram to expand its presence internationally.
- Diversification into new product categories: The company can explore diversifying its product offerings to include cannabis-infused beverages, edibles, and wellness products.
- Strategic partnerships: Collaborations with established brands or industry leaders can help OrganiGram strengthen its distribution network and gain market share.
Threats
- Intense competition: The cannabis industry is highly competitive, with numerous players vying for market share, which may impact OrganiGram's profitability.
- Regulatory uncertainties: Changes in cannabis regulations and government policies can pose challenges and disrupt business operations for OrganiGram.
- Health concerns and stigma: Negative perceptions surrounding cannabis use and potential health risks may affect consumer demand and overall market growth.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.